4//SEC Filing
Templeman Thomas 4
Accession 0000899243-21-022068
CIK 0001847903other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:00 PM ET
Size
8.7 KB
Accession
0000899243-21-022068
Insider Transaction Report
Form 4
Templeman Thomas
Chief Technology Officer
Transactions
- Purchase
Ordinary Shares
2021-06-02$20.00/sh+250$5,000→ 250 total - Award
Share Option (right to buy)
2021-04-20+500,338→ 500,338 totalExercise: $9.42Exp: 2031-04-20→ Ordinary Shares (500,338 underlying)
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]On May 20, 2021, the Issuer effected a share capital reorganization, which had the effect of a one for two reverse share split of the Issuer's share capital ("Share Split"). This amount has been adjusted to give effect to the Share Split.
- [F3]This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3
- [F4]25% of the shares subject to such option shall vest and become exercisable on May 17, 2022 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
- [F5]Represented A Ordinary Shares that were redesignated as Ordinary Shares immediately prior to the closing of the initial public offering.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001654274
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:00 PM ET
- Size
- 8.7 KB